(Q40945713)

25 September 2017

1 reference

title

Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study (English)

1 reference

25 September 2017

1 reference

Stehman FB

1

1 reference

25 September 2017

Bundy BN

series ordinal

2

1 reference

25 September 2017

Ball H

series ordinal

3

1 reference

25 September 2017

Clarke-Pearson DL

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

American Journal of Obstetrics and Gynecology

25 September 2017

published in

1 reference

25 September 2017

volume

174

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

1128-32; discussion 1132-3

1 reference

Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study)

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Changing concepts in the management of vulvar cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Squamous cell carcinoma of the vulva: a review of 424 patients, 1956-1974.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Carcinoma of the vulva: analysis of treatment failures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Prognostic variables in the treatment of squamous cell carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Recurrent squamous carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Use of Ranks in One-Criterion Variance Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Stage I squamous cell cancer of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Conservative surgical management of superficially invasive stage I vulvar carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Prognostic factors in early vulvar cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions-experience with 100 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

Potential Applications of Intraoperative Lymphatic Mapping in Vulvar Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970654-3

10.1016/S0002-9378(96)70654-3

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference